Suppr超能文献

[21-羟化酶缺乏症患者的CYP21基因点突变研究]

[CYP21 gene point mutations study in 21-hydroxylase deficiency patients].

作者信息

Liao Xiang-yun, Zhang Ya-fen, Gu Xue-fan

机构信息

Department of Pediatric Endocrinology, Genetics and Metabolism, Xinhua Hospital, Shanghai Second Medical University, Shanghai Institute for Pediatric Research, Shanghai 200092, China.

出版信息

Zhonghua Er Ke Za Zhi. 2003 Sep;41(9):670-4.

Abstract

OBJECTIVE

The major cause of congenital adrenal hyperplasia (CAH) is 21-hydroxylase deficiency, which accounts for 90% - 95% of all cases in most populations. This study was conducted to characterize the molecular basis of the 21-hydroxylase deficiency and to obtain the spectrum of the CYP21 gene mutations in a group of Chinese patients, and analyze the relationship of genotype and phenotype.

METHODS

To detect the distribution of gene mutations in Chinese population samples from 52 patients with 21-hydroxylase deficiency from 51 families were collected, including two parents samples in 30 patients and one parents sample in 10 patients. Blood samples were obtained for extraction of peripheral blood lymphocytes. Polymerase chain reaction (PCR) followed by nesed PCR were used to study the 21-hydroxylase gene (CYP21) mutations. The primary PCR amplified two overlapping CYP21-specific DNA fragments, The product of the nested PCR which used products from the primary PCR was analysed by restriction fragment length polymorphism (RFLP) or amplification-created restriction site (ACRS). All patients were studied by 6 mutations, including P30L, I2g (intron 2 nt 656 c/a-->g splice mutation), E3Delta8nt (exon 3 codon111-codon113 8 bp deletion), I172N, V281L and Q318X.

RESULTS

Through analysis of 52 patients with 21-hydroxylase deficiency, in 5 patients no mutations were detected, in 17 patients only one mutated allele could be characterized, two different mutations were identified in 21 patients, three mutations were detected in 2 patients. Totally, in 73% of alleles the genotypes could be detected. The most common mutation was I2g, which present on 31% affected alleles, then followed by I172N, Q318X, V281L, P30L, E3Delta8nt, accounting for 23%, 14%, 9%, 3%, 2% of all identified mutations respectively, which included multiple mutations accounting for 6%. The most frequent molecular defects of the salt-wasting form were the I2g (45.7%), Q318X (26%). Of the simple virilizing form, the dominant mutations were I172N (40.7%) and I2g (18.5%).

CONCLUSION

Six different mutations were examined in this study, and the detected mutations accounted for 73% affected alleles, in which I2g and I172N were the most common mutations (accounting for 54%). Correlation between genotypes and phenotypes was compatible with the reported data. Two rounds of PCR followed by RFLP or ACRS analysis may provide important information for genetic counseling and for prenatal diagnosis.

摘要

目的

先天性肾上腺皮质增生症(CAH)的主要病因是21-羟化酶缺乏,在大多数人群中占所有病例的90% - 95%。本研究旨在确定21-羟化酶缺乏的分子基础,获取一组中国患者中CYP21基因突变谱,并分析基因型与表型的关系。

方法

为检测中国人群样本中的基因突变分布,收集了来自51个家庭的52例21-羟化酶缺乏患者的样本,其中30例患者采集了双亲样本,10例患者采集了单亲样本。采集血样以提取外周血淋巴细胞。采用聚合酶链反应(PCR)及巢式PCR研究21-羟化酶基因(CYP21)突变。初次PCR扩增两个重叠的CYP21特异性DNA片段,以初次PCR产物为模板的巢式PCR产物通过限制性片段长度多态性(RFLP)或扩增产生的限制性位点(ACRS)进行分析。所有患者均检测6种突变,包括P30L、I2g(内含子2第656位核苷酸c/a→g剪接突变)、E3Delta8nt(外显子3第111密码子至第113密码子8 bp缺失)、I172N、V281L和Q318X。

结果

通过对52例21-羟化酶缺乏患者的分析,5例未检测到突变,17例仅鉴定出一个突变等位基因,21例鉴定出两种不同突变,2例检测到三种突变。总共73%的等位基因可检测到基因型。最常见的突变是I2g,存在于31%的受累等位基因上,其次是I172N、Q318X、V281L、P30L、E3Delta8nt,分别占所有鉴定突变的23%、14%、9%、3%、2%,其中包括6%的多重突变。失盐型最常见的分子缺陷是I2g(45.7%)、Q318X(26%)。单纯男性化型中,主要突变是I172N(40.7%)和I(18.5%)。

结论

本研究检测了6种不同突变,检测到的突变占73%的受累等位基因,其中I2g和I172N是最常见的突变(占54%)。基因型与表型的相关性与报道数据相符。两轮PCR后进行RFLP或ACRS分析可为遗传咨询和产前诊断提供重要信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验